Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure

Sodium–glucose cotransporter-2 inhibitors (SGLT2is) are a relatively new class of antidiabetic drugs that have shown favorable effects in heart failure (HF) patients, irrespective of the left ventricular ejection fraction (LVEF). Recent studies have demonstrated the beneficial effects of empaglifloz...

Descripción completa

Detalles Bibliográficos
Autores principales: Xanthopoulos, Andrew, Katsiadas, Nikolaos, Skoularigkis, Spyridon, Magouliotis, Dimitrios E., Skopeliti, Niki, Patsilinakos, Sotirios, Briasoulis, Alexandros, Triposkiadis, Filippos, Skoularigis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455594/
https://www.ncbi.nlm.nih.gov/pubmed/37629635
http://dx.doi.org/10.3390/life13081778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455594/
https://www.ncbi.nlm.nih.gov/pubmed/37629635
http://dx.doi.org/10.3390/life13081778

Ejemplares similares